Exchange: NASDAQ·Updated 04:00 AM EDT
NRSN logo

NRSN NeuroSense Therapeutics Ltd

$0.41
$0.0084
(2.09%)
Pre-Market
Prev Close $0.4016
Mkt Cap$15.51M
Vol100.00

About NRSN

Neurosense Therapeutics Ltd. is a clinical-stage biotechnology company, which engages n the discovery and development of targeted therapeutics for neurodegenerative diseases. The firm offers PrimeC, a therapy for amyotrophic lateral sclerosis (ALS). It also conducts testing of product candidates for the treatment of Parkinson's and Alzheimer's diseases. The company was founded by Alon Ben-Noon on February 13, 2017 and is headquartered in Herzliya, Israel.
54

Neutral Sentiment

How do you feel about NRSN?

Advertisement|Remove ads.